CN108699113A - 肽及其作为抗病毒剂的用途 - Google Patents

肽及其作为抗病毒剂的用途 Download PDF

Info

Publication number
CN108699113A
CN108699113A CN201680079962.8A CN201680079962A CN108699113A CN 108699113 A CN108699113 A CN 108699113A CN 201680079962 A CN201680079962 A CN 201680079962A CN 108699113 A CN108699113 A CN 108699113A
Authority
CN
China
Prior art keywords
peptide
amino acid
peptides
locus
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680079962.8A
Other languages
English (en)
Chinese (zh)
Inventor
M·R·穆罕默德易卜拉欣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vera Matisse Pte Ltd
Original Assignee
Vera Matisse Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vera Matisse Pte Ltd filed Critical Vera Matisse Pte Ltd
Publication of CN108699113A publication Critical patent/CN108699113A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201680079962.8A 2015-11-27 2016-11-28 肽及其作为抗病毒剂的用途 Pending CN108699113A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
MYPI2015002751A MY184269A (en) 2015-11-27 2015-11-27 Broad-spectrum anti-influenza virus therapeutic peptides
MYPI2015002751 2015-11-27
US201662335201P 2016-05-12 2016-05-12
US62/335,201 2016-05-12
US201662425913P 2016-11-23 2016-11-23
US62/425,913 2016-11-23
PCT/IB2016/057146 WO2017090010A1 (en) 2015-11-27 2016-11-28 Peptides and uses therefor as antiviral agents

Publications (1)

Publication Number Publication Date
CN108699113A true CN108699113A (zh) 2018-10-23

Family

ID=58763140

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680079962.8A Pending CN108699113A (zh) 2015-11-27 2016-11-28 肽及其作为抗病毒剂的用途

Country Status (7)

Country Link
US (1) US10538554B2 (https=)
EP (1) EP3380493A4 (https=)
JP (2) JP2019506840A (https=)
CN (1) CN108699113A (https=)
AU (1) AU2016359545B2 (https=)
MY (2) MY184269A (https=)
WO (1) WO2017090010A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110869040A (zh) * 2017-05-26 2020-03-06 维拉马蒂斯私人有限公司 肽及其用作抗病毒剂的用途

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021042039A1 (en) * 2019-08-29 2021-03-04 Ajk Pharmaceutical Llc Synthetic antimicrobial peptides
CN111100194B (zh) * 2020-02-21 2022-03-25 佛山科学技术学院 一种抗菌肽pd-l4在抑制禽流感病毒中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009040529A1 (en) * 2007-09-28 2009-04-02 Ulive Enterprises Limited Bacterial vaccine
US20130190228A1 (en) * 2008-06-13 2013-07-25 Wisconsin Alumni Research Foundation Novel antiviral peptides against influenza virus
US20130205416A1 (en) * 2010-07-28 2013-08-08 Anthony Nash Anti-viral agent
CN103360469A (zh) * 2004-05-04 2013-10-23 诺维信阿德宁生物技术公司 抗微生物多肽

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60221705T2 (de) * 2001-03-22 2008-06-05 The United States of America, represented by the Secretary, Dept. of Health and Human Services, the Natl. Institutes of Health, Office of Technology Transfer Glykosylierungsresistente cyanovirine und damit verbundene konjugate, zusammensetzungen, nukleinsäuren, vektoren, wirtszellen, herstellungsverfahren sowie verfahren zur verwendung nichtglykosylierter cyanovirine
US6930085B2 (en) * 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis
MX2007015105A (es) * 2005-06-01 2008-03-18 Variation Biotechnologies Inc Formulacion de vacuna de influenza a base de peptido.
US20070073039A1 (en) * 2005-09-29 2007-03-29 Chisari Francis V Peptides that inhibit viral infections
MY160435A (en) * 2008-06-12 2017-03-15 Univ Putra Malaysia A novel antiviral peptide against avian influenza virus h9n2
WO2013086499A2 (en) * 2011-12-09 2013-06-13 Ceres, Inc. Transgenic plants having altered biomass composition
EP3013425B1 (en) * 2013-06-27 2020-09-09 Rutgers, the State University of New Jersey Leukotoxin for use in the treatment of ocular disease
US11376306B2 (en) * 2017-05-26 2022-07-05 Viramatix Sdn Bhd Peptides and uses therefor as antiviral agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103360469A (zh) * 2004-05-04 2013-10-23 诺维信阿德宁生物技术公司 抗微生物多肽
WO2009040529A1 (en) * 2007-09-28 2009-04-02 Ulive Enterprises Limited Bacterial vaccine
US20130190228A1 (en) * 2008-06-13 2013-07-25 Wisconsin Alumni Research Foundation Novel antiviral peptides against influenza virus
US20130205416A1 (en) * 2010-07-28 2013-08-08 Anthony Nash Anti-viral agent

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DEEPAK T. NAIR等: ""Mimicry of Native Peptide Antigens by the Corresponding Retro-Inverso Analogs Is Dependent on Their Intrinsic Structure and Interaction Propensities"", 《THE JOURNAL OF IMMUNOLOGY》 *
MOHAMED RAJIK等: ""Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2"", 《VIROLOGY JOURNAL》 *
YANWEI ZHONG等: ""Mimotopes selected with neutralizing antibodies against multiple subtypes of influenza A"", 《VIROLOGY JOURNAL》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110869040A (zh) * 2017-05-26 2020-03-06 维拉马蒂斯私人有限公司 肽及其用作抗病毒剂的用途

Also Published As

Publication number Publication date
MY189021A (en) 2022-01-19
MY184269A (en) 2021-03-30
EP3380493A4 (en) 2019-07-31
US10538554B2 (en) 2020-01-21
US20180346516A1 (en) 2018-12-06
JP2022088370A (ja) 2022-06-14
AU2016359545A1 (en) 2018-07-12
AU2016359545B2 (en) 2021-06-10
JP2019506840A (ja) 2019-03-14
WO2017090010A1 (en) 2017-06-01
EP3380493A1 (en) 2018-10-03

Similar Documents

Publication Publication Date Title
EP2376100B1 (en) Peptidomimetic macrocycles
KR102570210B1 (ko) 펩티드모방 거대고리 및 이의 제제
CN101848719B (zh) 流感抑制组合物和方法
JP2022088370A (ja) 抗ウイルス剤としてのペプチドおよびこのための使用
US9221874B2 (en) Antiviral peptides against influenza virus
JP7233737B2 (ja) ペプチドおよび抗ウイルス剤としてのその使用
CN104628869B (zh) 一类兼具抗菌和抗流感病毒活性的融合肽衍生物
ES2710973T3 (es) Análogos de las defensinas beta cíclicas para el tratamiento de infecciones
RU2492178C1 (ru) Противовирусный пептид, подавляющий репликацию вируса гриппа
HK40025030A (en) Peptides and uses therefor as antiviral agents
Scala Design and synthesis of peptides involved in the inhibition of influenza virus infection
Raj et al. Current Research in Pharmacology and Drug Discovery
CN117062826A (zh) 抗感染双环肽配体
HK1142804B (en) Influenza inhibiting compositions and methods

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination